629 related articles for article (PubMed ID: 34097766)
1. Anticholinergic burden (prognostic factor) for prediction of dementia or cognitive decline in older adults with no known cognitive syndrome.
Taylor-Rowan M; Edwards S; Noel-Storr AH; McCleery J; Myint PK; Soiza R; Stewart C; Loke YK; Quinn TJ
Cochrane Database Syst Rev; 2021 May; 5(5):CD013540. PubMed ID: 34097766
[TBL] [Abstract][Full Text] [Related]
2. Anticholinergic burden for prediction of cognitive decline or neuropsychiatric symptoms in older adults with mild cognitive impairment or dementia.
Taylor-Rowan M; Kraia O; Kolliopoulou C; Noel-Storr AH; Alharthi AA; Cross AJ; Stewart C; Myint PK; McCleery J; Quinn TJ
Cochrane Database Syst Rev; 2022 Aug; 8(8):CD015196. PubMed ID: 35994403
[TBL] [Abstract][Full Text] [Related]
3. Anticholinergic deprescribing interventions for reducing risk of cognitive decline or dementia in older adults with and without prior cognitive impairment.
Taylor-Rowan M; Alharthi AA; Noel-Storr AH; Myint PK; Stewart C; McCleery J; Quinn TJ
Cochrane Database Syst Rev; 2023 Dec; 12(12):CD015405. PubMed ID: 38063254
[TBL] [Abstract][Full Text] [Related]
4. Association of Anticholinergic Burden with Cognitive Impairment and Health Care Utilization Among a Diverse Ambulatory Older Adult Population.
Campbell NL; Perkins AJ; Bradt P; Perk S; Wielage RC; Boustani MA; Ng DB
Pharmacotherapy; 2016 Nov; 36(11):1123-1131. PubMed ID: 27711982
[TBL] [Abstract][Full Text] [Related]
5. Anticholinergic Burden and Cognitive Impairment in Nursing Homes: A Comparison of Four Anticholinergic Scales.
Novella A; Elli C; Ianes A; Pasina L
Drugs Aging; 2023 Nov; 40(11):1017-1026. PubMed ID: 37620654
[TBL] [Abstract][Full Text] [Related]
6. Relation Between Delirium and Anticholinergic Drug Burden in a Cohort of Hospitalized Older Patients: An Observational Study.
Pasina L; Colzani L; Cortesi L; Tettamanti M; Zambon A; Nobili A; Mazzone A; Mazzola P; Annoni G; Bellelli G
Drugs Aging; 2019 Jan; 36(1):85-91. PubMed ID: 30484239
[TBL] [Abstract][Full Text] [Related]
7. Anticholinergic burden measures and older people's falls risk: a systematic prognostic review.
Stewart C; Taylor-Rowan M; Soiza RL; Quinn TJ; Loke YK; Myint PK
Ther Adv Drug Saf; 2021; 12():20420986211016645. PubMed ID: 34104401
[TBL] [Abstract][Full Text] [Related]
8. Anticholinergic Burden Measures Predict Older People's Physical Function and Quality of Life: A Systematic Review.
Stewart C; Yrjana K; Kishor M; Soiza RL; Taylor-Rowan M; Quinn TJ; Loke YK; Myint PK
J Am Med Dir Assoc; 2021 Jan; 22(1):56-64. PubMed ID: 32709405
[TBL] [Abstract][Full Text] [Related]
9. Multi-domain prognostic models used in middle-aged adults without known cognitive impairment for predicting subsequent dementia.
Mohanannair Geethadevi G; Quinn TJ; George J; Anstey KJ; Bell JS; Sarwar MR; Cross AJ
Cochrane Database Syst Rev; 2023 Jun; 6(6):CD014885. PubMed ID: 37265424
[TBL] [Abstract][Full Text] [Related]
10. Methodological challenges in determining longitudinal associations between anticholinergic drug use and incident cognitive decline.
Kashyap M; Belleville S; Mulsant BH; Hilmer SN; Paquette A; Tu le M; Tannenbaum C
J Am Geriatr Soc; 2014 Feb; 62(2):336-41. PubMed ID: 24417438
[TBL] [Abstract][Full Text] [Related]
11. Association of Anticholinergic Drug Burden with Cognitive and Functional Decline Over Time in Older Inpatients: Results from the CRIME Project.
Brombo G; Bianchi L; Maietti E; Malacarne F; Corsonello A; Cherubini A; Ruggiero C; Onder G; Volpato S
Drugs Aging; 2018 Oct; 35(10):917-924. PubMed ID: 30191516
[TBL] [Abstract][Full Text] [Related]
12. Anticholinergic medications and risk of dementia in older adults: Where are we now?
Chatterjee S; Talwar A; Aparasu RR
Expert Opin Drug Saf; 2020 Oct; 19(10):1251-1267. PubMed ID: 32797761
[TBL] [Abstract][Full Text] [Related]
13. Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the detection of dementia within community dwelling populations.
Quinn TJ; Fearon P; Noel-Storr AH; Young C; McShane R; Stott DJ
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD010079. PubMed ID: 34278562
[TBL] [Abstract][Full Text] [Related]
14. Anticholinergic medications in patients admitted with cognitive impairment or falls (AMiCI). The impact of hospital admission on anticholinergic cognitive medication burden. Results of a multicentre observational study.
Weichert I; Romero-Ortuno R; Tolonen J; Soe T; Lebus C; Choudhury S; Nadarajah CV; Nanayakkara P; Orrù M; Di Somma S;
J Clin Pharm Ther; 2018 Oct; 43(5):682-694. PubMed ID: 29729025
[TBL] [Abstract][Full Text] [Related]
15. Anticholinergic drugs and incident dementia, mild cognitive impairment and cognitive decline: a meta-analysis.
Pieper NT; Grossi CM; Chan WY; Loke YK; Savva GM; Haroulis C; Steel N; Fox C; Maidment ID; Arthur AJ; Myint PK; Smith TO; Robinson L; Matthews FE; Brayne C; Richardson K
Age Ageing; 2020 Oct; 49(6):939-947. PubMed ID: 32603415
[TBL] [Abstract][Full Text] [Related]
16. Drugs Contributing to Anticholinergic Burden and Risk of Fall or Fall-Related Injury among Older Adults with Mild Cognitive Impairment, Dementia and Multiple Chronic Conditions: A Retrospective Cohort Study.
Green AR; Reifler LM; Bayliss EA; Weffald LA; Boyd CM
Drugs Aging; 2019 Mar; 36(3):289-297. PubMed ID: 30652263
[TBL] [Abstract][Full Text] [Related]
17. Potentially Inappropriate Medication, Anticholinergic Burden, and Mortality in People Attending Memory Clinics.
Cross AJ; George J; Woodward MC; Ames D; Brodaty H; Wolfe R; Connors MH; Elliott RA
J Alzheimers Dis; 2017; 60(2):349-358. PubMed ID: 28869467
[TBL] [Abstract][Full Text] [Related]
18. Relation between anticholinergic burden and cognitive impairment: Results from the Monzino 80-plus population-based study.
Pasina L; Lucca U; Tettamanti M
Pharmacoepidemiol Drug Saf; 2020 Dec; 29(12):1696-1702. PubMed ID: 33098318
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for dementia in Parkinson's Disease - the overuse of anticholinergic drugs.
Malkiewicz JJ; Kasprzyk AG; Waksmundzki D; Węgrzynek J; Chmiela T; Siuda J
Neurol Neurochir Pol; 2023; 57(5):405-413. PubMed ID: 37357543
[TBL] [Abstract][Full Text] [Related]
20. Anticholinergic medication burden and cognitive function in participants of the ASPREE study.
Broder JC; Ryan J; Shah RC; Lockery JE; Orchard SG; Gilmartin-Thomas JF; Fravel MA; Owen AJ; Woods RL; Wolfe R; Storey E; Murray AM; Ernst ME
Pharmacotherapy; 2022 Feb; 42(2):134-144. PubMed ID: 34866212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
